Tag Archives: Molly McElwee Malloy

Diabetes By The Numbers: Molly McElwee Malloy talks about TypeZero’s NIH-funded study, and its partnership with CellNovo.

Welcome to Episode Ten of Diabetes By the Numbers.

Today we have our first returning guest. It’s Molly McElwee Malloy, Head of Patient Engagement at TypeZero Technologies in Charlottesville, Virginia. TypeZero is in the news this week for two big undertakings.

First, there’s a 12.7 million dollar artificial pancreas study funded by the National Institutes of Health. It will begin very soon. In this study, they’ll be testing TypeZero’s inControl platform, using a spiffy new device:
inControlAPapplication image
Cool, right? This study will include as many as 240 participants! The studies will take place in nine locations… six in the USA, and three in Europe. To find out more about participating in this important research, scroll to the bottom of this post.

The second big piece of news is this: Type Zero is entering into a partnership with CellNovo, which makes an integrated diabetes management system in Europe. They’ve gotten a lot of good press here in the USA, and we talk about that and what this partnership means for TypeZero. Have a listen:
DBTN

Reference Material – Click below for more information on this topic

Find out more about the inControl diabetes management platform by going to the Type Zero Technologies website:
http://typezero.com

Clinical trial participants are necessary and appreciated! Though the study will take place in several locations, the overall management of the trial will be handled through the Jaeb Center for Health Research. To contact the Jaeb Center to volunteer to participate, Send an e-mail to:
info@jaeb.org

To find out more about artificial pancreas testing through the University of Virginia’s Center for Diabetes Technology, send an e-mail to:
artificialpancreas@virginia.edu

CellNovo makes a diabetes management system that includes a patch pump, an activity monitor, a hand held cell-enabled handset, and a continuous glucose monitor. Data can be shared via the cloud. To learn more about CellNovo, go to:
CellNovo.com

Follow Molly McElwee Malloy on Twitter:
@MollyMacT1D

 

Diabetes By The Numbers: Type Zero Technologies.

Molly McElwee Malloy was my first interview here. She’s also my latest interview here.

A little over two months after the birth of Happy Medium, I saw Molly give a speech at a local JDRF meeting in Baltimore. At the time, she was clinical research coordinator at the Center for Diabetes Technology at the University of Virginia. She is also an RN and a Certified Diabetes Educator, and has been living with Type 1 Diabetes since 1998.

That was the first time I had seen anyone speak live about artificial pancreas development, how everything worked, and actually show me photos of the device they were testing. I was jazzed up about it, and the next day (and the day after that), I really bothered Molly for an interview. She said no, but said she would answer any questions I might have, so I could get all my facts straight.

In that instance as a new diabetes blogger with two months experience, and in the three years since, she has been kind, patient, and gracious when bombarded by my enthusiasm and my never-ending list of questions.

This month, Molly stepped into her latest role as Head of Patient Engagement at Type Zero Technologies, which is the commercial arm of AP research that was born many years ago at UVA’s Center for Diabetes Technology.

I am proud to say that she has finally gone on the record with me, for about 13 minutes, to talk about Type Zero and their InControl platform, including InControl Advice and InControl Cloud. She talks about those three products, the timing of upcoming clinical trials, and the plan for submitting these for approval to the U.S. Food and Drug Administration.

In reality, I wish we had more time, because this discussion could have easily gone two or three episodes. Instead, you’ll have to be satisfied with this little teaser, and then go to the Type Zero website to learn more.

Also, and this is important: Clinical trial participants are a very important piece of cutting-edge development like this. Please see below to find out more about volunteering to participate.
DBTN

Reference Material – Click below for more information on this topic

Find out more by going to the Type Zero Technologies website:
http://typezero.com

Follow Molly McElwee Malloy on Twitter:
@MollyMacT1D

Clinical trial participants are necessary and appreciated! Interested? Send an e-mail to:
artificialpancreas@virginia.edu
 

%d bloggers like this: